Asrat Agalu Abejew | Health Professions | Research Excellence Award

Dr. Asrat Agalu Abejew | Health Professions | Research Excellence Award

Bahir Dar University | Ethiopia

Dr. Asrat Agalu Abejew is a highly cited researcher whose work significantly advances antimicrobial resistance (AMR), antimicrobial stewardship (AMS), drug-use evaluation, and public-health pharmacotherapy. His prolific research portfolio spans more than 20 peer-reviewed journal publications, contributing impactful evidence on antibiotic consumption trends, prescribing behaviors, systemic resistance patterns, and medication-related adverse outcomes. He has published widely in reputable journals including The Lancet, PLoS ONE, BMC Research Notes, BioMed Research International, Heliyon, and the Canadian Journal of Infectious Diseases and Medical Microbiology. His research integrates structural equation modeling, AMR surveillance, antibiotic stewardship program evaluation, drug therapy problems, and health-system performance in resource-limited settings.

Citation Metrics (Scopus)

500

400

300

200

100

0

Citations
336

Documents
18

h-index
11

Citations

Documents

h-index

View Scopus Profile  View Google Scholar Profile

Featured Publications

 

Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

Mr. Romaric Tuono De Manfouo | Health Professions | Best Researcher Award

University of the Mountains | Cameroon

Mr. Romaric Tuono De Manfouo is an accomplished biomedical researcher specializing in hematology, infectious diseases, and public health. His work integrates laboratory investigations, epidemiological studies, and translational research to address pressing health challenges in sub-Saharan Africa. With a proven record of impactful scientific contributions, he has been involved in multidisciplinary projects exploring blood disorders, viral infections, and immunological responses. His ability to conduct rigorous clinical studies and collaborate with diverse research teams has positioned him as a respected figure in his field, committed to improving patient care through scientific advancement.

Professional Profile

Scopus

ORCID

Education

Mr. Romaric’s academic journey reflects a strong foundation in health sciences, with a focus on biomedical and clinical research. His studies provided comprehensive training in hematology, immunology, molecular biology, and epidemiology, allowing him to develop the expertise necessary to investigate complex medical conditions. Through extensive research training and practical exposure, he has acquired the skills to design and execute studies that address both laboratory-based and population-level health concerns.

Experience

Throughout his career, Mr. Romaric has worked in academic institutions, research laboratories, and collaborative health projects, contributing to knowledge generation and clinical decision-making. He has been a lead investigator and co-author on studies examining hematological profiles, hemostasis, infectious disease prevalence, and genetic conditions affecting blood health. His experience spans from advanced diagnostic testing to community-based data collection, making his work relevant to both clinical medicine and public health policy.

Research Interest

His research interests center on understanding the mechanisms and epidemiology of blood-related disorders such as sickle cell disease, glucose-6-phosphate dehydrogenase deficiency, and alloimmunization in chronic illness. He is equally engaged in studying infectious diseases including viral hepatitis and their impact on vulnerable populations such as pregnant women, newborns, and high-risk adult groups. His goal is to generate evidence that informs targeted interventions, improves early detection, and enhances patient outcomes in low-resource settings.

Awards

Mr. Romaric’s scientific achievements have been recognized through his publication record, invitations to review for international peer-reviewed journals, and collaborations with multidisciplinary research teams. His expertise is sought after in both academic and clinical research contexts, and his work continues to contribute to advancements in hematology, epidemiology, and public health.

Publications

  • Title: Abnormalities of Hemostasis in Sickle Cell Patients and Predisposition to Thrombotic Risk: A Systematic Review and Meta-Analysis
    Journal: Preprint
    Published on: 2025

  • Title: Inflammation and Iron Profile in Children With Sickle Cell Disease in Cameroon: Frequency and Associated Factors, an Analytical Cross‐Sectional Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case–Control Study
    Journal: Health Science Reports
    Published on: 2025

  • Title: Cytopenias and Associated Factors in Patients Living With HIV on ARV Treatment in Cameroon: An Analytical Cross‐Sectional Study
    Journal: Advances in Hematology
    Published on: 2025

  • Title: Haptoglobin Gene Polymorphism and Iron Profile in Sickle Cell Disease Patients With Inflammation in Yaounde, Cameroon
    Journal: Molecular Genetics & Genomic Medicine
    Published on: 2024

  • Title: Hematological And Hemostasis Profile, Thrombotic Risk In Sickle Cell Patient In Cameroon: An Analytical Cross-Sectional Study
    Journal: Hematology and Disorders
    Published on: 2024

  • Title: Hyperuricemia and Associated Factors: The Case of Outpatients at the Bafoussam Regional Hospital-Cameroon, an Analytical Cross-Sectional Study
    Journal: Health Science Reports
    Published on: 2024

Conclusion

Mr. Romaric Tuono De Manfouo exemplifies excellence in biomedical research, combining academic rigor, clinical insight, and a commitment to public health. His body of work reflects a consistent focus on improving the understanding, diagnosis, and management of hematological and infectious diseases in African populations. Through his scholarly publications, peer-review contributions, and research leadership, he continues to make significant contributions that enhance scientific knowledge and healthcare delivery. His achievements make him a worthy nominee for the Best Researcher Award, representing dedication, innovation, and scientific integrity.

Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Dr. Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Epidemiologist | Pfizer UK Ltd | United Kingdom

Dr. Andrew Vyse is a seasoned epidemiologist with extensive experience in both the pharmaceutical industry and public health research. He specializes in vaccine-preventable and potentially vaccine-preventable infections, contributing significantly to the field with over 80 peer-reviewed publications.

Profile

Scopus

Strengths for the Awards

  • Prolific Research Contributions:
    • Dr. Vyse has authored over 80 peer-reviewed publications, which demonstrates a consistent and significant contribution to epidemiological research, particularly in the area of vaccine-preventable diseases.
    • Recent publications cover diverse, critical topics such as Lyme disease, pneumococcal vaccination, RSV, and cost-effectiveness of vaccine strategies. This breadth indicates a comprehensive understanding of the field.
  • Impact on Public Health:
    • His work in vaccine-preventable diseases directly contributes to public health improvements, including informing vaccination strategies and addressing vaccine-preventable hospitalizations.
  • Industry and Academic Experience:
    • A balance of pharmaceutical industry experience (Pfizer and GSK) and public health research (UKHSA) highlights his ability to bridge scientific research with practical applications.
    • This unique positioning allows him to contribute to both policy-making and the development of new vaccine technologies.

Education 🎓

Dr. Vyse holds a PhD and MSc, reflecting his robust academic foundation in epidemiology and public health. His educational background has equipped him with the expertise to drive impactful research and clinical applications in his field.

Professional Experience 💼

  • Feb 2017 – Present: Clinical Epidemiologist at Pfizer UK Ltd, supporting the UK Medical Team and global Scientific Affairs for vaccines including pneumococcal, RSV, COVID, meningococcal, and a candidate Lyme vaccine.
  • Jan 2009 – Jan 2017: Global Epidemiologist at GSK Vaccines, contributing to portfolios for meningococcal, DTP, and rotavirus vaccines.
  • May 1993 – Dec 2008: Clinical Scientist at the UK Health Security Agency (formerly Public Health England), focusing on surveillance and epidemiological research for vaccine-preventable infections.

Research Interests On Medicine 🧬

Dr. Vyse’s research interests revolve around vaccine-preventable diseases, with a particular focus on respiratory infections, Lyme borreliosis, and strategies to optimize vaccination coverage in vulnerable populations.

Awards and Recognition 🏆

Dr. Vyse has been recognized for his contributions to epidemiology and vaccine research. His work has garnered significant academic and industry accolades, reflecting his impact on public health initiatives and vaccine development.

Publications 🔖

1. Estimating adult accident and emergency attendances in English hospitals attributed to respiratory syncytial virus

  • Authors: Vyse, A., Wright, H., Begier, E.
  • Year: 2024
  • Citations: 0

2. Using Catalytic Models to Interpret Age-Stratified Lyme Borreliosis Seroprevalence Data

  • Authors: Vyse, A., Colby, E.
  • Year: 2024
  • Citations: 0

3. Incidence of symptomatic Lyme borreliosis in nine European countries

  • Authors: Angulo, F.J., Colby, E., Lebech, A.-M., Moïsi, J.C., Stark, J.H.
  • Year: 2024
  • Citations: 1

4. Adult risk groups for vaccine-preventable respiratory infections: an overview of the UK environment

  • Authors: Reynard, C., Campling, J., Gordon, A.L., Wright, H., Ellsbury, G.
  • Year: 2024
  • Citations: 0

5. Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom

  • Authors: Wilson, M., Lucas, A., Mendes, D., Ellsbury, G.F., Perdrizet, J.
  • Year: 2023
  • Citations: 9

6. Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK

  • Authors: Schley, K., Kowalik, J.C., Sullivan, S.M., Tichy, E., Findlow, J.
  • Year: 2023
  • Citations: 0

7. Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?

  • Authors: Neri, M., Brassel, S., Schirrmacher, H., Steuten, L., Hamson, E.
  • Year: 2023
  • Citations: 4

8. A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019

  • Authors: Paradowska-Stankiewicz, I., Zbrzezniak, J., Skufca, J., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 5

9. Incidence of Lyme Borreliosis in Germany

  • Authors: Skufca, J., Tran, T.M.P., Brestrich, G., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 2

10. Incidence of Lyme Borreliosis in the Dutch General Practice Population

  • Authors: Houben, E., De Jong, H., Penning-Van Beest, F., Herings, R., Stark, J.H.
  • Year: 2023
  • Citations: 3

Conclusion 🌐

Dr. Andrew Vyse’s work bridges the pharmaceutical industry and public health research, driving innovations in vaccine development and disease prevention. His dedication to epidemiology continues to advance global health outcomes, underpinned by his extensive research, impactful publications, and commitment to public health initiatives.